Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
N/A
-200 Reduced 9.52%
1,900 $384,000
Q2 2022

Aug 12, 2022

BUY
N/A
100 Added 5.0%
2,100 $990,000
Q1 2022

May 13, 2022

SELL
N/A
-200 Reduced 9.09%
2,000 $1.18 Million
Q4 2021

Feb 11, 2022

SELL
N/A
-100 Reduced 4.35%
2,200 $1.59 Million
Q1 2021

May 13, 2021

SELL
N/A
-600 Reduced 20.69%
2,300 $1.33 Million
Q4 2020

Feb 10, 2021

SELL
N/A
-100 Reduced 3.33%
2,900 $1.67 Million
Q3 2020

Nov 13, 2020

BUY
N/A
100 Added 3.45%
3,000 $1.52 Million
Q2 2020

Aug 13, 2020

BUY
N/A
900 Added 45.0%
2,900 $1.27 Million
Q1 2020

May 14, 2020

BUY
N/A
700 Added 53.85%
2,000 $703,000
Q4 2019

Feb 13, 2020

BUY
N/A
100 Added 8.33%
1,300 $480,000
Q3 2019

Nov 13, 2019

BUY
N/A
100 Added 9.09%
1,200 $409,000
Q4 2018

Feb 13, 2019

BUY
N/A
1,100 New
1,100 $253,000

Others Institutions Holding BIO-B

About Bio-Rad Laboratories, Inc.


  • Ticker BIO-B
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 5,063,720
  • Market Cap $11.2B
More about BIO-B
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.